9 results
PCI in Acute MI with Cardiogenic Shock. #EBM #Cardiology #CULPRITSHOCK #PCI #VisualAbstract #NEJM
PCI in Acute MI ... #EBM #Cardiology ... #CULPRITSHOCK #PCI ... VisualAbstract #NEJM
Pulmonary and Non-Pulmonary Causes of ARDS #Diagnosis #EM #PCC #ARDS #Differential #Algorithm #Pulmonary #NonPulmonary #Causes #Ddxof
Pulmonary and Non-Pulmonary ... ARDS #Diagnosis #EM ... #PCC #ARDS #Differential ... #Algorithm #Pulmonary ... NonPulmonary #Causes #Ddxof
Associations between Total Mucin Concentrations and Phlegm Production and Disease Severity in Chronic Obstructive Pulmonary Disease
Chronic Obstructive Pulmonary ... #EBM #Pathophys ... #PCC #Bronchitis ... ChronicBronchitis #Mucin #NEJM
Trends in Platelet Adenosine Diphosphate P2Y12 Receptor Inhibitor Use and Adherence Among Antiplatelet-Naive Patients After Percutaneous
2681655 #Policy #EBM ... #AntiPlatelet #ADPInhibitor ... Ticagrelor #Plavix #PCI
Bivalirudin versus Heparin Monotherapy in Myocardial Infarction (VALIDATE-SWEDEHEART) #EBM #Cardiology #VALIDATE #SWEDEHEART #Bivalirudin #Heparin #PCI #VisualAbstract
VALIDATE-SWEDEHEART) #EBM ... Bivalirudin #Heparin #PCI ... VisualAbstract #NEJM
PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock - Event Rates of the
PCI Strategies in ... #EBM #Cardiology ... #CULPRITSHOCK #PCI ... #cardiogenic #NEJM
Event Rates of the Primary End Point and Its Components at 30 Days #EBM #Cardiology #CULPRIT-SHOCK
Components at 30 Days #EBM ... #CULPRITSHOCK #PCI ... #cardiogenic #NEJM
Algorithm for Evaluation of Suspected Pulmonary Embolism #Diagnosis #EM #IM #PCC #PulmonaryEmbolism #Pulmonary #Embolism #DDimer #CTA
Evaluation of Suspected Pulmonary ... Embolism #Diagnosis #EM ... #IM #PCC #PulmonaryEmbolism ... #Pulmonary #Embolism ... CTA #Algorithm #Ddxof
Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation (RE-DUAL PCI trial) - Shown is
Dabigatran after PCI ... Fibrillation (RE-DUAL PCI ... warfarin (Panel A) #EBM ... TripleTherapy #PCI ... AtrialFibrillation #NEJM